Marketwatch syrs
WebSyros Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SYRS updated stock price target summary. Web3 apr. 2024 · SYRS: Syros Pharmaceuticals - Brokerage Recommendations Chart - Zacks.com Syros Pharmaceuticals (SYRS) (Delayed Data from NSDQ) $2.56 USD -0.11 …
Marketwatch syrs
Did you know?
WebSyros Pharmaceuticals ( NASDAQ:SYRS ) Full Year 2024 Results Key Financial Results Revenue: US$14.9m (down 37% from FY... Q4 2024 Syros Pharmaceuticals Inc … WebMarketWatch Dow Jones Ensysce Biosciences Shares Soar 37% on Final Study Stage Initiation of PF614-MPAR Jan. 25, 2024 at 1:52 p.m. ET Other News Press Releases Why Y-mAbs Therapeutics Shares Are...
WebSYRS Complete Syros Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SYRS Syros Pharmaceuticals Inc. SEC Filings MarketWatch Home Investing … Syros Pharmaceuticals Inc. options data by MarketWatch. View SYRS option ch… WebFor their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.28 per share, missing the Zacks Consensus Estimate of -$1.27 per share. This reflects a negative earnings surprise of...
WebVandaag · Goolsbee said he is focused on whether there is a credit crunch in the wake of the collapse of Silicon Valley Bank in March. The Chicago Fed president, who is a voting … Web15 mrt. 2024 · Syros Pharmaceuticals, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $7.8 million for the quarter ended December 2024, surpassing the Zacks...
WebSYRS Growth Metrics The 5 year net cashflow from operations growth rate now stands at 7.16%. The year over year cash and equivalents growth rate now stands at -67.74%. The 3 year net cashflow from operations growth rate now stands at -84.69%. SYRS's revenue has moved up $3,920,000 over the prior 15 months.
WebThe strongest trend for SYRS is in Sentiment, which has been heading up over the past 179 days. SYRS ranks lowest in Stability; there it ranks in the 18th percentile. SYRS Stock Summary Revenue growth over the past 12 months for SYROS PHARMACEUTICALS INC comes in at -36.65%, a number that bests merely 5.71% of the US stocks we're tracking. rabin pythonWebGet the latest Syros Pharmaceuticals Inc (SYRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … rabin scott theoremWebSYRS U.S.: Nasdaq Syros Pharmaceuticals Inc. Watch list Create SYRS Alert After Hours Last Updated: Feb 3, 2024 7:57 p.m. EST Delayed quote $ 5.21 0.16 3.17% After Hours … shocking a spaWeb20 apr. 2024 · Today's Change (0.68%) $1.35 Current Price $199.92 Key Data Points Market Cap $118B Day's Range $196.21 - $201.17 52wk Range $170.12 - $223.31 Volume 1,557,248 Avg Vol 3,162,829 Gross Margin 33.23%... rabin research company reviewsWeb31 mrt. 2024 · SYRS -2.15% DJIA 0.01% Russell 2K 0.00% Health Care/Life Sciences 0.39% Overview News Syros Pharmaceuticals Inc. Significant News Only No significant news for SYRS in the past two years. Key... rabin schumann and partnersWebSyros Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest SYRS financial statements, income statements and financial ratios. rabin sheldon mdWebDownload Syros Pharmaceuticals Inc. stock data: historical SYRS stock prices from MarketWatch. shocking asia watch